Pazzagli L

Consistency between the National Patient Register and the Swedish Cancer Register.

Sakakibara S, Pazzagli L, Linder M

Pharmacoepidemiol Drug Saf 33 (4) e5780 [2024-04-00; online 2024-03-21]

Model misspecification and bias for inverse probability weighting estimators of average causal effects.

Waernbaum I, Pazzagli L

Biom J 65 (2) e2100118 [2023-02-00; online 2022-08-31]

Rationale and performances of a data-driven method for computing the duration of pharmacological prescriptions using secondary data sources.

Pazzagli L, Liang D, Andersen M, ..., Khan AR, Sessa M

Sci Rep 12 (1) 6245 [2022-04-15; online 2022-04-15]

The use of uncertain exposure-A method to define switching and add-on in pharmacoepidemiology.

Pazzagli L, Linder M, Reutfors J, Brandt L

Pharmacoepidemiol Drug Saf 31 (1) 28-36 [2022-01-00; online 2021-10-01]

Methods for constructing treatment episodes and impact on exposure-outcome associations.

Pazzagli L, Brandt L, Linder M, ..., Andersen M, Bahmanyar S

European journal of clinical pharmacology 76 (2) 267-275 [2020-02-00; online 2019-11-22]